Vanotech

Index
Globenewswire

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Globenewswire

Vanotech Appoints Matthew Schiller to Lead Business Development